Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that it enclosed details of the scheduled Investor Meeting as on Tuesday 25 April, 2023 which will be attended by the representatives of the Company.
The above information is a part of company’s filings submitted to BSE.